Fig. 2
From: Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme
Experimental validation of high CCL2 expression in GBM. A, B Immunohistochemistry (IHC) staining of CCL2 with a GBM tissue microarray. The normal brain tissue was used as a control. Scale bar, 200 µM. C CCL2 expression in representative GBM cell lines obtained from the CCLE dataset. D The transcript level of CCL2 in 4 available GBM cell lines and a normal brain glial SVGP12 cells was detected by qRT-PCR analysis. Data are the mean ± s.d (n = 3). Student’s t-test. ** p < 0.01